On August 26, 2024, Robert Stephenson, Chief Financial Officer of Omega Healthcare Investors Inc (OHI, Financial), executed a sale of 30,000 shares of the company. The transaction was filed on the same day with the SEC. Following this sale, the insider now owns 205,618 shares of Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. The company's portfolio includes investments in the United States and the United Kingdom.
The shares were sold at a price of $38.78 each, valuing the transaction at approximately $1,163,400. This sale has contributed to a total of three insider sells over the past year, with no insider buys recorded during the same period.
As of the latest trading session, Omega Healthcare Investors Inc has a market cap of approximately $10.13 billion. The stock's price-earnings ratio stands at 29.98, which is above both the industry median of 16.74 and the company's historical median.
The current stock price relative to the GF Value of $30.21 suggests that Omega Healthcare Investors Inc is modestly overvalued, with a price-to-GF-Value ratio of 1.28.
The GF Value is calculated considering historical trading multiples, an adjustment factor based on past returns and growth, and future business performance estimates provided by Morningstar analysts.
This insider sale might interest investors tracking ownership changes and evaluating the stock's current valuation against market and intrinsic value metrics.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
